BridgeBio Oncology Therapeutics, Inc. (BBOT)
NASDAQ: BBOT · Real-Time Price · USD
9.09
-0.04 (-0.44%)
Mar 13, 2026, 4:00 PM EDT - Market closed

BBOT Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22
Cash & Equivalents
373.6930.85--
Short-Term Investments
51.77124.78--
Cash & Short-Term Investments
425.46155.63--
Cash Growth
173.38%---
Accounts Receivable
0.390.08--
Other Current Assets
6.552.98--
Total Current Assets
432.4158.69--
Net Property, Plant & Equipment
3.290.49--
Other Long-Term Assets
12.75.120.330.14
Total Assets
448.38164.30.330.14
Accounts Payable
1.373.070.02-
Accrued Expenses
32.3712.75--
Current Portion of Leases
0.52---
Other Current Liabilities
0.773.750.380.17
Total Current Liabilities
35.0419.580.40.17
Long-Term Leases
2.24---
Total Long-Term Liabilities
2.24---
Total Liabilities
37.2919.580.40.17
Common Stock
0.01-00
Additional Paid-in Capital
767.6443.540.020.02
Accumulated Other Comprehensive Income
0.020.35--
Retained Earnings
-356.57-222.52-0.09-0.05
Minority Interest
-323.36--
Shareholders' Equity
411.1-178.64-0.06-0.02
Total Liabilities & Equity
448.38164.30.330.14
Total Debt
2.77000
Net Cash (Debt)
422.69155.63-0-0
Net Cash Growth
171.60%---
Net Cash Per Share
13.5712061.61--
Book Value
411.1-178.64-0.06-0.02
Book Value Per Share
13.20-13844.61-0.02-0.01
Tangible Book Value
411.1-178.64-0.06-0.02
Tangible Book Value Per Share
13.20-13844.61-0.02-0.01
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.